このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

The Utility of Clinical Milestones Pathway in a Cardiovascular ICU

2016年8月10日 更新者:Adam Kingeter、Vanderbilt University

The Utility of an Electronic Based Milestone Pathway on the Care of Patients Undergoing Cardiac Valve Surgery

The economic burden of health care is becoming a greater burden from year to year. Medicare spending, which represented 20 percent of national health spending in 2013, grew 3.4 percent to $585.7 billion, a slowdown from growth of 4.0 percent in 2012. This slowdown was attributed largely to slower enrollment growth and impacts of the Affordable Care Act (ACA) and sequestration. Per-enrollee spending in 2013 grew at about the same rate as 2012.

The push to create Accountable Care Organizations (ACO) has taken these initiatives a step further. The goal would be to move away from a fee for service system and base reimbursement on quality of care. Clinical metrics, re-admissions, and patient satisfaction in categories of acute myocardial infarction, congestive heart failure, pneumonia, surgeries and healthcare associated infections will be the foci for 2013. Centers for Medicare and Medicaid Services (CMS) has also initiated a valve bundled payment system that encompasses total patient care for 90 days, including readmissions.

Leapfrog and the ACO movement along with the nonprofit group Institute for Health Care Improvement have placed quality and cost effectiveness into the spotlight for clinicians in the ICU and beyond. While clinicians have always been focused on evidence based therapies with little concern for cost, in the new era of healthcare understanding cost, value and effectiveness of therapies will be key for improved patient outcomes and institutional solvency in trying economic times.

Vanderbilt elected to enroll in the CMS valve bundle trial. The Leadership team in the heart and vascular institute identified the importance of an electronic medical record that includes display and utilization of key drivers of quality and success across the continuum of care (Preoperative assessment to discharge up to 90 days) in the bundled payment model of care. A multidisciplinary team was developed in conjunction with nurses, midlevel providers, multi-specialty physicians, case managers, informatics specialists, and performance improvement representatives to develop an electronic pathway of care using evidence based and best practices for cardiac surgery.

調査の概要

状態

完了

条件

詳細な説明

A multidisciplinary team consisting of physicians, pharmacists, nutritionists, social workers, bedside nurses, physical therapists, and mid-level providers developed the structure and key elements of the milestone pathway. The Vanderbilt University Informatics Team developed the electronic version of the consensus milestones. The pathway encompasses 17 phases beginning with the pre-procedure evaluation and continuing through the perioperative period until the three-month follow-up post procedure. The nursing staff performed documentation of pathway stages during the index hospitalization, and the milestone stage was displayed on the door of the patient's room. The milestone stage was discussed on multi-disciplinary bedside rounds in the ICU, and if a patient could not progress to the next stage the nurse would document the reason for failure to progress.

In this study, the investigators compared patients who underwent valve surgery with the milestone pathway in place, to patients who underwent valve surgery without the milestone pathway in place. Patients were adjusted according to baseline characteristics such as demographics, procedure, and proceduralist collected from the electronic medical record and Society of Thoracic Surgeons (STS) database.

The investigators primary clinical outcome is mortality, and secondary clinical outcomes include the incidence of re-intubation within 48 hours, acute kidney injury as defined by Kidney Disease Improving Global Outcome (KDIGO) criteria, delirium, major adverse cardiac events (MACE), and infection rates for catheter and central line associated infections as well as sternal wound infection. In addition the investigators examined financial outcomes including variance in direct and total cost, and direct and total cost per patient.

研究の種類

観察的

入学 (実際)

2401

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

16年歳以上 (子、大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

サンプリング方法

非確率サンプル

調査対象母集団

All patients who underwent cardiac valve surgery at vanderbilt university medical center between 1/1/2013 and 12/31/2014

説明

Inclusion Criteria:

  • Underwent cardiac valve surgery at vanderbilt university medical center between 1/1/2013 and 12/31/2014

Exclusion Criteria:

  • none

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

コホートと介入

グループ/コホート
介入・治療
Pre intervention
This cohort consists of patients who underwent cardiac valve surgery during calender year 2013 prior to the institution of the electronic milestone pathway
post intervention
This cohort consists of patients who underwent cardiac valve surgery during calender year 2014 after the electronic milestone pathway had been instituted
an electronic based, clinical milestone driven pathway developed to guide the care of cardiac valve surgery patients.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
mortality
時間枠:Post operative day 0 to post operative day 7
mortality rate for patients during index hospitalization
Post operative day 0 to post operative day 7

二次結果の測定

結果測定
メジャーの説明
時間枠
Re-intubation rate within 48 hours
時間枠:48 hours of index procedure
re-intubation rate within 48 hours of index procedure for patients undergoing cardiac surgery
48 hours of index procedure
Acute Kidney Injury as defined by KDIGO (Kidney Disease Improving Global Outcomes) guidelines
時間枠:All time points occurring between post operative day 0 and Post operative day 7
Incidence of acute Kidney Injury as defined by KDIGO (Kidney Disease Improving Global Outcomes) guidelines during index hospitalization
All time points occurring between post operative day 0 and Post operative day 7
Delirium
時間枠:All time points occurring between post operative day 0 and Post operative day 7
Incidence of delirium as defined by Intensive Care Unit Confusion Assessment Method (ICU-CAM) scoring system during index hospitalization
All time points occurring between post operative day 0 and Post operative day 7
major adverse cardiac events
時間枠:All time points occurring between post operative day 0 and Post operative day 7
Incidence of major adverse cardiac events defined as death, need for re-operation, myocardial infarction during index hospitalization
All time points occurring between post operative day 0 and Post operative day 7
Infection rates
時間枠:All time points occurring between post operative day 0 and Post operative day 7
defined as Catheter Associated Urinary Tract Infection (CAUTI), Central Line Associated Blood Stream Infection (CLABSI), sternal wound infection during index hospitalization
All time points occurring between post operative day 0 and Post operative day 7
Direct cost
時間枠:All time points occurring between post operative day 0 and Post operative day 7
summation of costs directly attributable to patient care during index hospitalization
All time points occurring between post operative day 0 and Post operative day 7
total cost
時間枠:All time points occurring between post operative day 0 and Post operative day 7
summation of costs directly attributable to patient care, as well as costs to the patient which are not directly attributable to patient care (unspecified charges to patient such as OR utilization fees, laboratory staff fees, etc.)
All time points occurring between post operative day 0 and Post operative day 7
variance in cost
時間枠:All time points occurring between post operative day 0 and Post operative day 7
total and direct costs attributable to each patient undergoing cardiac valve surgery will be averaged for all patients undergoing cardiac valve surgery during the study period. Each individual patient's direct and total costs will then be compared to the averaged cost for all patients undergoing cardiac valve surgery hospitalization to obtain a variance in cost for each individual patient undergoing cardiac valve surgery. The investigators will then compare average variance between the two cohorts.
All time points occurring between post operative day 0 and Post operative day 7

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Lee Parmley, MD, JD、Vanderbilt University Medical Center

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始

2013年1月1日

一次修了 (実際)

2014年12月1日

研究の完了 (実際)

2014年12月1日

試験登録日

最初に提出

2016年7月13日

QC基準を満たした最初の提出物

2016年8月8日

最初の投稿 (見積もり)

2016年8月11日

学習記録の更新

投稿された最後の更新 (見積もり)

2016年8月12日

QC基準を満たした最後の更新が送信されました

2016年8月10日

最終確認日

2016年8月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • IRB #151566

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

心臓手術の臨床試験

electronic milestone pathwayの臨床試験

3
購読する